IRCT201203018954N1
Completed
未知
Aspirin for prevention of adverse pregnancy outcome in women with elevated alfa-feto protein in second trimester screening,a randomised clinical trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Elevated level of alfa fetoprotein in second trimester screening.
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 109
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusin criteria:16\-20 gestational weeks pregnant women who attend Imam khomeini hospital clinic of perinatology,and have a second trimester AFP\>2\.5 MOM.They are divided into 2 groups with or without aspirin.
- •Patients are included in study who deliver in Imam khomeini hospital.
- •Exclusion criteria :maternal medical disease and uterus anomalies
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Investigating the Role of Aspirin in patients with preexisting Diabetes in order to reduce the occurance of pregnancy complications.EUCTR2014-001332-11-IERoyal College of Surgeons23
Completed
Not Applicable
Preterm Birth Prevention Study follow-up in looking at Neurodevelopmental delayCTRI/2021/06/034432Thrasher Research Fund4,820
Completed
Phase 3
ASPIRIN- Preterm Birth Prevention StudyCTRI/2016/05/006970Eunice Kennedy Shriver National Institute of Child Health and Human Development4,829
Recruiting
Phase 1
Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology.Preeclampsia during pregnancyTherapeutic area: Diseases [C] - Pathological Conditions, Signs and Symptoms [C23]Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]CTIS2022-500933-10-00Centre Hospitalier Universitaire De Toulouse1,164
Completed
Phase 2
The effect of Aspirin in pregnancy outcome in patients with abnormal down syndrome blood tests and normal karyotypepregnancy.Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and deliveryP00-P96IRCT2014120620218N1Vice chancellor for research, Kerman University of Medical Sciences85